SPHK1 and prostate carcinoma: However, the diagnostic value of circulating Sphk1/S1P, unlike miRNAs, needs further investigation since there has no acceptable reference levels, although it has been reported that circulating S1P and erythrocyte Sphk1 activity could be a biomarkers for early prostate cancer detection [39].